major molecular response
Showing 1 - 25 of >10,000
Atopic Dermatitis Trial in San Francisco (Dupilumab)
Recruiting
- Atopic Dermatitis
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 4, 2023
CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)
Recruiting
- CML
- Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
-
Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, ArgentinaFUNDALEU
Jun 29, 2023
Depressive Disorder, Major, Treatment Outcome, Cognitive Dysfunction Trial in Copenhagen (Treatment Package for First-Episode
Recruiting
- Depressive Disorder, Major
- +4 more
- Treatment Package for First-Episode Depression
-
Copenhagen, DenmarkNeurobiology Research Unit, Rigshospitalet
Nov 12, 2022
Perioperative Adiponectin and Postoperative Inflammatory
Recruiting
- Obesity, Abdominal
- +3 more
- serum levels of adiponectin
- +3 more
-
Osijek, Croatia
- +1 more
Sep 25, 2023
According to Molecular Identification at Diagnosis
Not yet recruiting
- Chronic Myeloid Leukemia
- Next Generation Sequencing (DNA and RNA)
- (no location specified)
Oct 28, 2022
Effect of Pharmacogenetics on Imatinib Plasma Level and Response
Active, not recruiting
- Chronic Myeloid Leukemia
- PCR
- HPLC-UV
-
Assiut, EgyptSouth Egypt Cancer Institute
Aug 6, 2022
Major Depressive Disorder With Anhedonia and Inadequate Response
Not yet recruiting
- Depressive Disorder, Major
- No Intervention
- (no location specified)
Apr 24, 2023
Crohn's Disease, Ulcerative Colitis Trial (Samples)
Not yet recruiting
- Crohn's Disease
- Ulcerative Colitis
- Samples
- (no location specified)
Feb 8, 2023
Prediction of Adolescents With MDD Response to ECT Via MRI
Recruiting
- Major Depressive Disorder
- +2 more
- Modified Electroconvulsive Therapy
- Conventional pharmacotherapy
-
Chongqing, Province, ChinaThe First Affiliated Hospital of Chongqing Medical University
May 26, 2023
Major Depression Response to Citalopram Therapy in Anorexia
Recruiting
- Anorexia Nervosa
- Citalopram i.v. and p.o
- Citalopram p.o
-
Oggebbio, ItalyIstituto Auxologico Italiano
Mar 21, 2023
REsponse to Depression Interventions Using Clinical and TD-fNIRS
Enrolling by invitation
- Depression
- Major Depressive Disorder
- fNIRS measurement
-
La Jolla, California
- +2 more
Aug 17, 2023
MDD Trial in Gwangju (stepwise pharamacotherapy, antidepressant monotherapy group)
Recruiting
- Major Depressive Disorder
- stepwise pharamacotherapy
- antidepressant monotherapy group
-
Gwangju, Korea, Republic ofChonnam National University Hospital
Sep 19, 2023
Major Depression Trial in Rouffach (Repetitive transcranial magnetic stimulation (rTMS))
Recruiting
- Major Depression
- Repetitive transcranial magnetic stimulation (rTMS)
-
Rouffach, Alsace, FranceCentre Hospitalier Rouffach
Jul 26, 2023
MDD Trial in Atlanta (Ketamine, Placebo)
Recruiting
- Major Depressive Disorder
- Ketamine
- Placebo
-
Atlanta, GeorgiaEmory University
Dec 20, 2022
Healthy Volunteer, MDD, Depression Trial run by the NIMH (drug, other, device)
Recruiting
- Healthy Volunteer
- +2 more
- Ketamine
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 12, 2023
Athletic Performance, Muscle Fatigue, Oxidative Stress Trial in Olomouc (Hydrogen rich water, Placebo)
Enrolling by invitation
- Athletic Performance
- +2 more
- Hydrogen rich water
- Placebo
-
Olomouc, CzechiaPalacky University, Faculty of Physical Culture
Apr 11, 2023
MDD Trial in Tulsa (LPS, Saline)
Recruiting
- Major Depressive Disorder
- LPS
- Saline
-
Tulsa, OklahomaLaureate Institute for Brain Research
Jun 29, 2022
Treatment Response Biomarkers in MDD
Recruiting
- Major Depressive Disorder
-
Changsha, Hunan, ChinaCentral South University
Oct 17, 2022
Depression, Bipolar, MDD, Bipolar Disorder Trial (Blood sampling)
Not yet recruiting
- Depression, Bipolar
- +2 more
- Blood sampling
- (no location specified)
Oct 3, 2022
MDD Trial in Columbia (TMS treatment)
Completed
- MDD
- TMS treatment
-
Columbia, MissouriUniversity of Missouri Neuromodulation Center
Dec 8, 2022
Inflammatory Response, Weakness, Muscle Trial (Methylprednisolone, NaCl 0.9%)
Recruiting
- Inflammatory Response
- Weakness, Muscle
- Methylprednisolone
- NaCl 0.9%
-
Genk, BelgiumZiekenhuis Oost-Limburg
Jan 25, 2023
Depression, MDD, Mild Depression Trial in Abbotsford (Psilocybin)
Not yet recruiting
- Depression
- +4 more
-
Abbotsford, British Columbia, CanadaCentre for Neurology Studies x Upstream
Oct 25, 2022
Near Patient Molecular Testing in Sepsis
Active, not recruiting
- Sepsis
- Systemic Inflammatory Response Syndrome
-
Los Angeles, California
- +2 more
Jul 19, 2022
Stage III Breast Cancer AJCC V7 Trial in Bergen (epirubicin/docetaxel sequential)
Active, not recruiting
- Stage III Breast Cancer AJCC V7
- epirubicin/docetaxel sequential
-
Bergen, NorwayDept of Oncology
Jun 24, 2022
Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)
Not yet recruiting
- Depressive Disorder, Major
- +2 more
- Ketamine
- +2 more
-
New Haven, ConnecticutYale University
Jun 26, 2023